Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit

Inclusion Criteria: * Male and female subjects 18 - 80 years of age * Patients undergoing radical cystectomy for treatment of bladder cancer clinically staged as no greater than T2, N0 * Indicated and agreed between physician investigator and patient to have an incontinent conduit as the diversion mechanism of choice post cystectomy Exclusion Criteria: * History of other cancer within the past 5 years (except non metastatic prostate or non melanoma skin cancer) * Evidence of cancer metastasis * History of any pelvic radiation or non-pelvic radiation within past 5 years * Debilitating cardiac or pulmonary disease * Expected need for chemotherapy within 3 months post cystectomy * Life expectancy less than 2 years